x

US approves first oral pill for treatment of COVID-19

The US Food and Drug Administration (FDA) has authorised Pfizer’s antiviral pill, Paxlovid, to treat COVID-19.

This is the first antiviral COVID-19 pill authorised for sick people to take at home before they are sick enough to be hospitalised.

Paxlovid combines a new antiviral drug named nirmatrelvir and an older one called ritonavir and is administered as three pills given twice a day for five days.

In a statement on Wednesday, the FDA said those eligible for the pill include high-risk individuals age 12 and older who weigh at least 88 pounds and have a positive SARS-CoV-2 test are eligible.

It said Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.

Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said the pill is a major step forward in the fight against this global pandemic.

“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19,“ she said.

The agency, however, warned that “Paxlovid is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in those requiring hospitalization due to severe or critical COVID-19”.

“Paxlovid is not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended. The FDA has approved one vaccine and authorized others to prevent COVID-19 and serious clinical outcomes associated with a COVID-19 infection, including hospitalization and death. The FDA urges the public to get vaccinated and receive a booster if eligible,” it said.

It said the side effects of Paxlovid include impaired sense of taste, diarrhea, high blood pressure and muscle aches, adding that using the pill at the same time as certain other drugs may result in potentially significant drug interactions.

Hot this week

North-Central APC Forum Backs Mutfwang, Rejects Plateau APC Leaders’ Move to Block Defection

By Israel Adamu, JosThe North-Central All Progressives Congress (APC)...

Today’s Headlines: Galatasaray Recoup €31m From Osimhen Deal; ‘Nigeria...

Sunday, 26 October 2025 Premier League15:00 CET AFC BournemouthvNottm Forest ...

Agribusiness revolution key to Nigeria’s economic recovery- Lawmaker

By Ogenyi Ogenyi,UyoA member of the Akwa Ibom Assembly,...

ALSTDI Commends President Tinubu for Extending Adebomehin’s Tenure, Hails Progress in Geospatial Intelligence and National Mapping Reforms

….Says extension reflects confidence in performance and continuity….Urges Surveyor-General...

ALSTDI Commends Tinubu for Extending Adebomehin’s Tenure, Praises Geospatial and Mapping Reforms

….Says extension reflects confidence in performance and continuity….Urges Surveyor-General...

The Global Governance Initiative and the Quest for a Multipolar World

By Prof. Udenta O. UdentaThe world is changing, and...

Wednesday 29 October 2025

Serie A18:30 CET ComovVerona 18:30 CET JuventusvUdinese 18:30 CET RomavParma 20:45...

Justine Madugu Signs New Two-Year Deal as Super Falcons Coach

Super Falcons head coach Justine Madugu has confirmed that...

ATA 1–1 MIL: Match Review and Updated Serie A...

Lookman Rediscovers Scoring Form Ahead of Nigeria’s World Cup Playoff

Ademola Lookman finally ended his goal drought on Tuesday...

Related Articles

Popular Categories

spot_imgspot_img